Sägepalme Extrakt (Saw palmetto)
Food supplement declared in France, declaration No 2021-6-1293, decision dated 24 June 2021
Sägepalme Extrakt (Saw palmetto) (Vegavero) is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Serenoa repens 300 mg per day, Triglycérides à chaine moyenne. 1 rule of use applies to its ingredients (limits and warnings).
- Brand
- Vegavero
- Food business operator placing the product on the market
- Vanatari International GmbH
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Capsule
- Daily dose
- 1
- Directions for use
- Prenez 1 gélule par jour avec suffisamment de liquide pendant un repas.
- Intended populations
- Men
- Not recommended (according to the manufacturer)
- Adolescents (under 18)
- Objectives stated by the manufacturer (these are not authorised claims)
- Urinary system
Declaration 226034, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Serenoa repens (W.Bartram) Small | Fruit | Extrait au CO2 supercritique | 300 mg |
Other active ingredients
| Name | Per day |
|---|---|
| Triglycérides à chaine moyenne | not declared |
Additives
Hydroxypropyl Méthyl Cellulose, E140
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Label warnings
Les compléments alimentaires ne se substituent pas à une alimentation saine et variée ni à un exercice physique régulier. Ne pas dépasser la dose journalière indiquée. L'emploi est déconseillé chez les femmes en âge de procréer et aux moins de 18 ans. Demandez l'avis de votre médecin et/ou pharmacien avant de prendre le complément. Tenir hors de portée des enfants. Conserver dans un endroit sombre, réfrigéré et sec.
Regulatory points
- Conditions légales
Serenoa repens (W.Bartram) Small: L'étiquetage doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé ("Demander l'avis de votre médecin et /ou pharmacien").
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Serenoa repens (W.Bartram) Small
Read the warning, when it applies and the studies cited
SAW PALMETTO – SERENOA REPENS
Route of administration: Oral
Cautions and warnings
Condition of application: All subpopulations.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Condition of application: Adult males only.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use to exclude a diagnosis of prostate cancer (USP-NF 2024; Mills and Bone 2005).
Sources cited by Health Canada (2)
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
- USP-NF 2024: United States Pharmacopeia and the National Formulary. Rockville (MD): The United States Pharmacopeial Convention, Inc.; 2024.
Condition of application: Adult females only.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking oral contraceptives or hormone replacement therapy (UpToDate 2024).
Sources cited by Health Canada (1)
- UpToDate 2024. UpToDate database. Clinical use of Saw palmetto. [Consulted 2024 December 5]. Available from : https://www.uptodate.com/contents/clinical-use-of-saw-palmetto?search=saw%20palmetto&source=search_result&selectedTitle=1%7E9&usage_type=default&display_rank=1
Contraindications
Condition of application: Adult females only.
Do not use if you are pregnant, breastfeeding, or attempting to conceive (UpToDate 2024).
Sources cited by Health Canada (1)
- UpToDate 2024. UpToDate database. Clinical use of Saw palmetto. [Consulted 2024 December 5]. Available from : https://www.uptodate.com/contents/clinical-use-of-saw-palmetto?search=saw%20palmetto&source=search_result&selectedTitle=1%7E9&usage_type=default&display_rank=1
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Brand : Vegavero
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Sägepalme Extrakt (Saw palmetto) (Vegavero): composition and regulation”, https://compoatlas.com/en/supplements/products/226034-sagepalme-extrakt-saw-palmetto, updated 15 November 2026.